Neck Cancer Current Events | Neck Cancer News | 8
|
| Page
8 of
92 |
1835 Results |
|
|
|
Sort By:
Page Views | Date |
Who gets cancer treatment, and who completes it?
Cancer treatment is now very effective in many cases, yet not all patients with cancer are referred and not all complete their treatment programme. This has puzzled cancer specialists who have wondered if psychological factors might influence their decision and has led to research carried out by Dr Stan Lindsay from the Institute of Psychiatry in... view more... (2002-11-13)
Drug for anemic cancer patients raises risk of death
Millions of cancer patients take drugs to boost their red blood cells and health when they become anemic after chemotherapy. view more (2008-02-27)
Study examines factors associated with survival in advanced laryngeal cancer
Type of treatment, sex, race and insurance status are associated with survival rates among patients with advanced laryngeal cancer, according to a report in the December issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. view more (2007-12-18)
UAB First in U.S. to Offer Speedier Precise Cancer Therapy
The University of Alabama at Birmingham (UAB) this month became the first U.S. medical center to offer a speedier cancer radiation therapy. The new technique can turn a 20-minute radiotherapy session into a 90-second session for selected patients. view more (2008-05-08)
Common antibacterial treatment linked to sensorineural hearing loss in cystic fibrosis patients
An otherwise effective treatment for cystic fibrosis places patients at a high risk of sensorineural hearing loss, according to new research published in the July edition of Otolaryngology-Head and Neck Surgery. view more (2009-07-01)
Minimally invasive approach can work for many thyroid patients
Many patients with diseased thyroids have two safe, effective treatment options that can dramatically reduce the size of their neck incisions and speed recovery, researchers say. view more (2006-03-16)
Denosumab increases bone density, cuts fracture risk in prostate cancer survivors
Twice-yearly treatment with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. view more (2009-08-11)
Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
Celecoxib, the anti-inflammatory medication also known by the trade name Celebrex, has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung, according to a study from The University of Texas M. D. Anderson Cancer Center. view more (2008-05-16)
Novel and Effective Treatment for Soft Tissue Sarcoma in Children
Rhabdomyosarcoma is a highly malignant aggressive form of soft tissue cancer in children, the causes of which are currently unknown. Although the fibrous growths can be found all over the body they commonly develop around the head, neck, bladder and testes in young boys. The most common age for onset is between 1-5 years of age. The treatments... view more... (2004-07-15)
Bilateral cochlear implants: A case when 2 are definitely superior to 1
A study of cochlear implant patients seen by Indiana University School of Medicine physicians is the first research to show evidence that cochlear implants in both ears significantly improves quality of life in patients with profound hearing loss and that the cost of the second implant is offset by its benefits. view more (2008-05-30)
New treatment option for ruptured brain aneurysms
Researchers in Finland have identified an effective new treatment option for patients who have suffered a ruptured brain aneurysm, a potentially life-threatening event. Results of the new study on stent-assisted coil embolization were published today in the online edition of Radiology. view more (2009-08-26)
Pitt researchers develop less risky treatment for depression, seizures
Researchers from the University of Pittsburgh, with the help of a team of Pittsburgh high school science teachers, have developed a wireless device that is implanted in the neck to fight depression and epileptic seizures. view more (2006-01-20)
Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus:
Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus: view more (1999-08-11)
Robotic device appears useful for surgical removal of cancer involving the tonsils
A new robotic surgery technique appears promising for the removal of cancer involving the tonsil region, according to a report in the December issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. view more (2007-12-18)
Genes signal late-stage laryngeal cancer, poorer outcome
Researchers at Henry Ford Hospital have identified tumor-suppressing genes that may provide a more accurate diagnosis of disease stage and survival for laryngeal cancer patients than current standards. view more (2009-10-08)
Carefully Mixed Radiation Cocktail Reduces Collateral Damage In Breast Cancer Patients
A carefully determined mixture of electron and x-ray beams precisely treated breast tumors while significantly reducing collateral skin damage in 78 patients. view more (2006-07-31)
Researchers train the immune system to deliver virus that destroys cancer in lab models
An international team of researchers led by Mayo Clinic have designed a technique that uses the body's own cells and a virus to destroy cancer cells that spread from primary tumors to other parts of the body through the lymphatic system. view more (2007-12-19)
Search reveals molecules that block Stat 3
Finding molecules that block the activity of the oncogene Stat3 (signal transducer and activator of transcription) required screening literally millions of compounds, using computers that compared the structure of the cancer-causing gene to those of the small molecules, said a Baylor College of Medicine researcher in a report that appears in the... view more... (2009-03-11)
PROSTATE CANCER SERIES (p 859)
A four-week series about prostate cancer-the third most common cancer in men worldwide, and the leading male cancer in Europe and North America-begins in this week's issue of THE LANCET. The first article, by Henrik Grönberg of Umea University, Sweden, assesses the epidemiology of prostate cancer, and examines the impact of genetic and... view more... (2003-03-05)
Merck's odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
Two-year data from a Phase IIB study of odanacatib (formerly MK-0822), an investigational, selective cathepsin-K inhibitor in development for the treatment of osteoporosis by Merck & Co., Inc., demonstrated dose- dependent increases in bone mineral density (BMD) at the total hip, lumbar spine and femoral neck fracture sites and decreased... view more... (2008-09-17)
|
|
| Page
8 of
92 |
1835 Results |
|
|
|
Sort By:
Page Views | Date |
|
